Company intelligence / Profile preview

Albemarle

Charlotte, North Carolina, United States

Ownership: Private
Employees: ~8300
Development stage: Other

Overview

Albemarle does not conduct clinical research but is a key supplier of custom reagents and specialty chemicals to pharmaceutical companies for drug synthesis, enabling innovation in small molecule therapeutics. Its expertise is crucial in synthetic chemistry, especially for small molecules and organometallic reagents, foundational to drug development.

Modalities: Small moleculeOrganometallic
Industry: Chemicals & Materials

Partnerships

Trusted by leading pharma and nutrition companies for supply of APIs and reagentsJoint ventures with Jordan Dead Sea Industries Company and Arab Potash Company for bromine production

Beyond the preview

Go deeper on Albemarle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Albemarle.

Explore the full profile